Skip to main content

Alithya Group inc. Class A Subordinate Voting Shares (ALYA)

About The Company

ALYA Stock Market Logo

Alithya Group Inc is a leader in Strategy and digital transformation, with professionals in Canada, the US, and Europe. Its integrated offering is laid out as follows: Strategy, custom solutions, Microsoft solutions, and Oracle solutions. Clients entrust the company with their strategic projects across Banking, Investment and Insurance, Energy, Manufacturing, Retail and Distribution, Telecommunications, Transportation, Professional Services, Healthcare, and Government sectors. Geographically, it derives a majority of revenue from Canada. The company’s services include digital transformation, enterprise technology, solution development, project management, infrastructure management, and others.

IPO Year Sector Industry

Alithya Group inc. Subordinate Voting Shares (ALYA) Latest News

Company Contact & Address (ALYA)

Corporate Headquarters Phone Website
H3B 3A5,
+1 514 227-6434 Official ALYA Website

ALYA Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector N/A P/E Ratio Not Available
Industry N/A Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALYA

Jobs & Employment at Alithya Group inc. Subordinate Voting …

LinkedIn Company Page
Official Career & Employment Page Careers & Jobs at Alithya Group inc. Subordinate Voting Shares (ALYA)

Related & Similar Stock Symbols

SRI Stock Market Price & News


Stoneridge Inc. Common Stock

NAACU Stock Market Price & News


North Atlantic Acquisition Corporation Unit

CRXTW Stock Market Price & News


Clarus Therapeutics Holdings Inc. Warrants